This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1992 Sep;66(3):424-6.

doi: 10.1038/bjc.1992.290.

Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges

PMID: 1520579
PMCID: PMC1977946
DOI: 10.1038/bjc.1992.290

Free PMC article

Editorial

Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges

J M Birch. Br J Cancer. 1992 Sep.

Free PMC article

. 1992 Sep;66(3):424-6.

doi: 10.1038/bjc.1992.290.

Author

PMID: 1520579
PMCID: PMC1977946
DOI: 10.1038/bjc.1992.290

No abstract available

PubMed Disclaimer

Similar articles

A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
Law JC, Strong LC, Chidambaram A, Ferrell RE. Law JC, et al. Cancer Res. 1991 Dec 1;51(23 Pt 1):6385-7. Cancer Res. 1991. PMID: 1933902
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D, et al. Birch JM, et al. Cancer Res. 1994 Mar 1;54(5):1298-304. Cancer Res. 1994. PMID: 8118819
Testing for germ line p53 mutations in cancer families.
Li FP, Correa P, Fraumeni JF Jr. Li FP, et al. Cancer Epidemiol Biomarkers Prev. 1991 Nov-Dec;1(1):91-4. Cancer Epidemiol Biomarkers Prev. 1991. PMID: 1845175 No abstract available.
[Li-Fraumeni syndrome].
Frebourg T. Frebourg T. Bull Cancer. 1997 Jul;84(7):735-40. Bull Cancer. 1997. PMID: 9339200 Review. French.
[Germline mutations of the p53 gene].
Frebourg T. Frebourg T. Pathol Biol (Paris). 1997 Dec;45(10):845-51. Pathol Biol (Paris). 1997. PMID: 9769948 Review. French.

See all similar articles

Cited by

Transgeneration carcinogenesis: a review of the experimental and epidemiological evidence.
Tomatis L. Tomatis L. Jpn J Cancer Res. 1994 May;85(5):443-54. doi: 10.1111/j.1349-7006.1994.tb02378.x. Jpn J Cancer Res. 1994. PMID: 8014100 Free PMC article. Review. No abstract available.
Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.
Sorrell AD, Espenschied CR, Culver JO, Weitzel JN. Sorrell AD, et al. Mol Diagn Ther. 2013 Feb;17(1):31-47. doi: 10.1007/s40291-013-0020-0. Mol Diagn Ther. 2013. PMID: 23355100 Free PMC article. Review.
Tumourigenesis associated with the p53 tumour suppressor gene.
Chang F, Syrjänen S, Tervahauta A, Syrjänen K. Chang F, et al. Br J Cancer. 1993 Oct;68(4):653-61. doi: 10.1038/bjc.1993.404. Br J Cancer. 1993. PMID: 8398688 Free PMC article.
Age-specific oncogenesis: the genetics of cancer susceptibility.
Malkin D. Malkin D. Environ Health Perspect. 1995 Sep;103 Suppl 6(Suppl 6):37-9. doi: 10.1289/ehp.95103s637. Environ Health Perspect. 1995. PMID: 8549486 Free PMC article. Review.

References

1. N Engl J Med. 1992 May 14;326(20):1309-15 - PubMed
1. N Engl J Med. 1992 May 14;326(20):1301-8 - PubMed
1. Cancer Res. 1991 Nov 15;51(22):6094-7 - PubMed
1. Science. 1990 Nov 30;250(4985):1233-8 - PubMed
1. Nature. 1991 Jun 6;351(6326):453-6 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal